N
Nancy L. Barrett
Researcher at Connecticut Agricultural Experiment Station
Publications - 17
Citations - 3936
Nancy L. Barrett is an academic researcher from Connecticut Agricultural Experiment Station. The author has contributed to research in topics: Population & Streptococcus pneumoniae. The author has an hindex of 15, co-authored 17 publications receiving 3853 citations.
Papers
More filters
Journal ArticleDOI
Active bacterial core surveillance of the emerging infections program network.
Anne Schuchat,Hilger T,Elizabeth R. Zell,Monica M. Farley,Arthur Reingold,Lee H. Harrison,Lewis Lefkowitz,Richard Danila,Karen Stefonek,Nancy L. Barrett,D. Morse,Robert W. Pinner +11 more
TL;DR: In 1998, early-onset group B streptococcal disease had declined by 65% over the previous 6 years, and 25% of invasive pneumococcal infections in ABCs areas were not susceptible to penicillin, and 13.3% were not susceptibility to three classes of antibiotics.
Journal ArticleDOI
Epidemiology of Invasive Streptococcus pneumoniae Infections in the United States, 1995-1998: Opportunities for Prevention in the Conjugate Vaccine Era
Katherine Robinson,Wendy Baughman,G. Rothrock,Nancy L. Barrett,Margaret Pass,Catherine Lexau,Barbara Damaske,Karen Stefonek,Brenda Barnes,Jan E. Patterson,Elizabeth R. Zell,Anne Schuchat,Cynthia G. Whitney +12 more
TL;DR: Young children, elderly persons, and black persons of all ages are disproportionately affected by invasive pneumococcal disease, and current ACIP recommendations do not address a subset of persons aged 18 to 64 years but do include those at highest risk for death from invasive pneumonia.
Journal ArticleDOI
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997.
Daniel R. Feikin,Anne Schuchat,Margarette S. Kolczak,Nancy L. Barrett,Lee H. Harrison,Lewis B. Lefkowitz,Allison McGeer,Monica M. Farley,Duc J. Vugia,Catherine Lexau,Karen Stefonek,Jan E. Patterson,James H. Jorgensen +12 more
TL;DR: Older age and underlying disease remain the most important factors influencing death from pneumococcal pneumonia.
Journal ArticleDOI
The Epidemiology of Invasive Group A Streptococcal Infection and Potential Vaccine Implications: United States, 2000–2004
Rosalyn O'Loughlin,Rosalyn O'Loughlin,Angela Roberson,Paul R. Cieslak,Ruth Lynfield,Ken Gershman,Allen S. Craig,Bernadette A. Albanese,Monica M. Farley,Monica M. Farley,Nancy L. Barrett,Nancy L Spina,Bernard Beall,Lee H. Harrison,Arthur Reingold,Chris A. Van Beneden,Active Bacterial Core Surveillance Team +16 more
TL;DR: The introduction of a vaccine could significantly reduce morbidity and mortality due to invasive GAS infections in the United States, and the potential impact of a multivalent GAS vaccine is estimated.
Journal ArticleDOI
Epidemiology of Invasive Group A Streptococcus Disease in the United States, 1995–1999
Katherine L. O'Brien,Bernard Beall,Nancy L. Barrett,Paul R. Cieslak,Arthur Reingold,Monica M. Farley,Monica M. Farley,Richard Danila,Elizabeth R. Zell,Richard R. Facklam,Benjamin Schwartz,Anne Schuchat +11 more
TL;DR: It is estimated that 9600-9700 cases of invasive GAS disease occur in the United States each year, resulting in 1100-1300 deaths, and older age; presence of streptococcal toxic shock syndrome, meningitis, or pneumonia; and infection with emm1 or emm3 were all independent predictors of death.